CT

Nearly a third of the 25 radiology-related applications passing FDA muster in April address radiation oncology. The rest were split among MRI, ultrasound, image management, and nuclear medicine. Standouts included two ultrasound systems, an x-ray

Adding to its investment in positron imaging, Integral Nuclear Associates has purchased the assets of Nuclear Imaging Systems and Cardiovascular Concepts. These assets include 14 fixed-site nuclear cardiology imaging centers in Pennsylvania, New Jersey,

Nuclear Associates, a division of Inovision, has agreed to exclusively offer Howtek MultiRAD medical film digitizers. The digitizers will be marketed alongside Nuclear Associates’ radiation oncology and diagnostic products, which include quality

NeoSpect, a product for noninvasive diagnosis of suspected lung cancer, has entered the European market. The nuclear medicine product has been on the U.S. market since 1999 under the trade name NeoTect, which is being comarketed by Nycomed Amersham and

Philips Medical Systems has appointed Gary Burbach chief executive officer of ADAC Laboratories. ADAC, a vendor of nuclear medicine equipment and radiation therapy planning systems, was acquired by Philips in December 2000. Prior to the acquisition,

The obvious targets for merger and acquisition are gone. The flurry of purchases undertaken in 2000 pretty much cleared the deck of single-modality vendors. SMV is part of GE; ADAC Laboratories has become the nuclear medicine division of Philips; Agilent

Rankled by proposed revisions to the long-standing regulations that govern diagnostic nuclear medicine, two trade organizations have filed a joint petition asking the Nuclear Regulatory Commission to revoke a portion of a pending rule that would impose

By Robert BruceRoyal Philips Electronics announced last week that it has agreed to acquire ADAC Laboratories for $426 million, or $18.50 a share of ADAC's outstanding common stock. The offer is subject to regulatory approval. It is good until Dec. 12 and

Company shows big growth in PET and gamma cameras Based in large part on substantial sales growth for its PET and gamma camera products, Siemens Medical Systems has laid claim to the top market share spot worldwide in nuclear medicine.Siemens

SMV’s Positrace, the first commercially available PET/CT system, obtained FDA 510(k) clearance Sept. 1, just days before the European Association of Nuclear Medicine meeting began in Paris.Although GE Medical Systems has a 510(k) clearance for its

GE Medical Systems and Elscint have reached an agreement in which GE will acquire Elscint’s 50% share of ELGEMS, a joint venture formed in 1997 by the two companies to manufacture nuclear imaging systems, for $30 million.As a result of the

Marconi Medical Systems has a new offering in its line of nuclear medicine products. The single-head system, called Meridian, complements the existing line of dual- and triple-head cameras that have become the company’s standard bearers.Meridian

Marconi Medical Systems is expanding its oncology business beyond CT to MR and nuclear medicine with new screening tools and is signing business agreements with several companies and international health centers.Marconi formally launched its

At this year’s Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at

Will increase FDG output and sales forcePharmaceutical manufacturer Syncor of Woodland Hills, CA, struck three deals this month that will expand its presence and customer base in the nuclear medicine industry. The company aims to build the

Multimodality fusion imaging dominates SNM showThe concept of fusion imaging is new enough that the industry has yet to sort out the acronyms, but this month’s Society of Nuclear Medicine show in St. Louis made it clear combined

ADAC Laboratories has a first customer for its recently approved Skylight nuclear medicine camera: Cedars-Sinai Medical Center in Los Angeles.Cedars-Sinai placed an order for the $1 million imaging device, along with a C-PET positron emission

ADAC Laboratories and American Diagnostic Medicine have signed an agreement with the International Oncology Network to offer PET imaging services to the network's 2000 oncologists. This agreement is an offshoot of the "First Nuclear" joint venture

French firm Medasys has created another U.S. subsidiary, e.Merging Medical, to market information management and workflow products to medical OEM vendors. Medasys already has an established U.S. division in Miami that pursues the nuclear medicine and

The Society of Nuclear Medicine announced its first exclusive alliance with a single industry vendor when it joined with General Electric Medical Systems to develop educational programs for the nuclear medicine community.According to the agreement, the

Syncor Overseas, a subsidiary of nuclear pharmaceutical and medical imaging company Syncor, has acquired MRI Trinidad and Tobago, an MRI center in Port of Spain, Trinidad and Tobago. Syncor acquired the center from Magnetic Resonance Imaging of Trinidad

ADAC Laboratories, a manufacturer of nuclear medicine and radiation therapy planning systems, believes it is tapping into a new market for CT simulation products with the introduction of its SmartSim package. SmartSim is an integrated CT simulation and

Nuclear cardiac perfusion studies are growing “by leaps and bounds,” according to an industry analyst, while cardiac MR and cardiac CT hover around 1% of total studies in those modalities.In 1993, cardiac perfusion studies made up only 38% of

Nuclear medicine and RIS/PACS vendor ADAC Laboratories has brought some new faces to its management team. James Haisler has been named COO of the vendor’s Dallas-based healthcare information systems division. Haisler most recently served as

Nuclear medicine firms arrived at the RSNA meeting optimistic about the modality’s potential for growth. Despite an overall flat market in 1999, vendors predict sales will climb over the next two years from $700 million to more than $1 billion,